Funds · 13F filer · Baltimore, MD

AIGH Capital Management LLC

$1.1B in 42 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

Returns–Not enough quarters yet

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
SNDKSandisk Corp$338.8M30.7%−25.5%
MXLMaxlinear Inc$104.7M9.5%New
INTCIntel Corp$87.1M7.9%New
APPSDigital Turbine Inc$84.5M7.6%+33.8%
SIMOSilicon Motion Technology Co$48.0M4.3%−28.0%
CLFDClearfield Inc$40.1M3.6%New
MEIMethode Electrs Inc$31.8M2.9%New
ASYSAmtech Sys Inc$28.9M2.6%New
FENCFennec Pharmaceuticals Inc$26.7M2.4%+25.5%
KYTXKyverna Therapeutics Inc$24.9M2.3%+39.8%
Nyxoah S ACUSIP B6S7WD106$24.6M2.2%New
PSNLPersonalis Inc$23.0M2.1%−40.9%
Sophia Genetics SaCUSIP H82027105$22.8M2.1%New
DDD3d Sys Corp Del$22.0M2.0%New
VUZIVuzix Corp$19.6M1.8%+104.7%
ABEOAbeona Therapeutics Inc$18.5M1.7%−3.6%
ARDXArdelyx Inc$16.3M1.5%New
BDSXBiodesix Inc$15.3M1.4%−10.5%
SPRBSpruce Biosciences Inc$13.5M1.2%New
CSTLCastle Biosciences Inc$13.0M1.2%−7.7%
VNDAVanda Pharmaceuticals Inc$12.5M1.1%−25.7%
PTHSPelthos Therapeutics Inc$9.3M0.8%New
Polypid LtdCUSIP M8001Q126$7.6M0.7%−5.6%
VSTMVerastem Inc$7.4M0.7%−3.6%
BWENBroadwind Inc$5.6M0.5%New

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
NRXSNeuraxis IncMarch 31, 2025+240.0%$3.8M
SIMOSilicon Motion Technology CoMarch 31, 2026+196.8%$48.0M
PSNLPersonalis IncSeptember 30, 2024+149.1%$23.0M
FENCFennec Pharmaceuticals IncMarch 31, 2025+76.5%$26.7M
BDSXBiodesix IncMarch 31, 2026+55.5%$15.3M
WATTEnergous CorpMarch 31, 2026+53.3%$4.4M
APYXApyx Medical CorporationDecember 31, 2025+28.3%$5.1M
VUZIVuzix CorpMarch 31, 2026+25.5%$19.6M
COYACoya Therapeutics IncDecember 31, 2022+23.5%$3.7M
ABEOAbeona Therapeutics IncDecember 31, 2025+17.3%$18.5M

Sold off last quarter

  • ZBRAZebra Technologies Corporati was $20.9M
  • LASRNlight Inc was $19.4M
  • GNRCGenerac Hldgs Inc was $17.6M
  • RRXRegal Rexnord Corporation was $14.0M
  • LRMRLarimar Therapeutics Inc was $13.5M
  • Esperion Therapeutics Inc NeCUSIP 29664W105 was $12.1M
  • ZVRAZevra Therapeutics Inc was $11.2M
  • IDNIntellicheck Mobilisa Inc was $10.6M
  • TARAProtara Therapeutics Inc was $8.5M
  • BKTIBk Technologies Corporation was $2.4M

Quarter by quarter

QuarterIts picksS&P 500
March 31, 2026+32.0%−4.6%
December 31, 2025+18.2%+2.4%
September 30, 2025+27.4%+7.8%
June 30, 2025+19.0%+10.5%
March 31, 2025−20.2%−4.6%
December 31, 2024+14.0%+2.1%
September 30, 2024−0.7%+5.4%
June 30, 2024−3.0%+4.0%
March 31, 2024+3.7%+10.0%
December 31, 2023+13.9%+11.2%
September 30, 2023−17.2%−3.6%
June 30, 2023−4.3%+8.3%
March 31, 2023−2.3%+7.0%
December 31, 2022+7.2%+7.1%
September 30, 2022+4.2%−5.3%
June 30, 2022−9.6%−16.5%
March 31, 2022−14.7%−4.9%
December 31, 2021+2.2%+10.7%
September 30, 2021−9.3%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1835943
  2. 2
    Filed August 7, 2026 · accession 0001214659-26-009749